Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)Gilbert Donders, Johan Van Eldere, Geert Byttebier et al.|American Journal of Obstetrics and Gynecology|2008Cited by 126
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A. Voss, Rohit Vashisht, Kevin Haynes et al.|EClinicalMedicine|2023Cited by 27